Dr. Amaria on Genetically Modified TILs in Melanoma
1 意见
• 07/03/23
0
0
嵌入
Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论